Written by Ad OpsHistory and Breeding Intent
MediKit is a CBD-forward cannabis cultivar developed by Buddha Seeds, a Spanish breeder known for stability trials and phenotype selection. Released in the mid-2010s, it was conceived during the rapid rise of health-oriented cannabis varieties that prioritized cannabidiol over intoxicating THC. The breeder’s goal was explicit: concentrate CBD into a dependable hybrid that retained rich aroma, vigor, and yield while minimizing psychoactivity. In practice, MediKit quickly became a reference point for European growers seeking high CBD content with professional-grade consistency.
Buddha Seeds has consistently marketed the line as a balanced indica and sativa hybrid, optimized to produce a calm, functional experience. Unlike many early CBD strains that sacrificed terpene richness for chemotype stability, MediKit was selected to keep a pronounced citrus and tropical fruit bouquet. The breeder subsequently released an autoflowering counterpart, often listed as Medikit Auto by seed banks and media outlets. CannaConnection’s sitemap, for example, indexes Medikit Auto as a related cultivar, reflecting the line’s push into both photoperiod and autoflower segments.
The exact founding parents have not been publicly disclosed by Buddha Seeds, a common practice when breeders guard proprietary selections. However, MediKit’s positioning in genealogy listings suggests it belongs to a modern wave of CBD-rich hybrids that were selected against high THC outcomes. Public genealogical indices occasionally place MediKit in the orbit of known clone-only lines and unnamed selections, underlining how CBD-focused breeding pulled from diverse and sometimes confidential sources. This secrecy is consistent with industry norms where unique chemotypes represent significant intellectual property.
In the wider landscape, MediKit emerged just as CBD demand accelerated in Europe and North America. Patient communities were seeking predictable CBD-to-THC ratios for daytime relief without impairment, and cultivators wanted reliable, high-yield seed lines to meet that demand. MediKit found success because it answered both ends of the equation: commercial-grade output and repeatable cannabinoid ratios. Its strong foothold in EU markets also reflects the region’s tighter limits on THC content in CBD products.
Over time, reports from growers and retailers portrayed MediKit as a stable performer that rarely throws out high-THC outliers under typical conditions. That stability helps dispensaries and CBD boutiques advertise consistent effects and compliance. As legalization and medical programs matured, MediKit became a go-to seed option for operators prioritizing non-intoxicating flower that still smells and tastes like premium cannabis. The result is a cultivar that bridges medical utility with connoisseur-grade sensory quality.
Genetic Lineage and Classification
MediKit is explicitly presented by the breeder as an indica and sativa hybrid, a balanced architecture chosen to blend fast vegetative growth with sturdy flowering structure. While Buddha Seeds has not released the full pedigree, the line expresses traits common to CBD-dominant selections influenced by North American hybrid stock. The emphasis on citrus and sweet tropical notes points toward terpene selections in the limonene and myrcene families. This profile is consistent with many modern CBD cultivars that evolved from multi-parent projects rather than a single classic cross.
Public genealogy aggregators occasionally situate MediKit alongside clone-only benchmarks and unnamed background lines. A seed genealogy listing that groups OG Kush (clone only), Harlequin (clone only), and hybrids involving unknown strains also references MediKit by Buddha Seeds. The appearance of MediKit in proximity to such entries does not prove direct parentage but indicates its placement in broader hybrid lineages commonly used to stabilize CBD-forward chemotypes. In other words, it sits within the web of modern CBD breeding without a breeder-confirmed family tree.
What is unambiguous is its chemotype: MediKit is purpose-bred to express high CBD with minimal THC. Practical outcomes reported by growers are CBD-rich flowers that routinely surpass a 20 to 1 CBD to THC ratio when environmental controls are adequate. This makes MediKit attractive in jurisdictions where product categories are regulated by THC thresholds. It also simplifies dosing for consumers who prefer negligible intoxication.
Beyond the photoperiod version, the breeder and retailers offer an autoflowering sibling frequently labeled Medikit Auto. Autoflowering versions inherit day-length independence by incorporating ruderalis genetics, allowing rapid cycles of roughly 10 to 11 weeks from seed in many garden setups. The core sensory and CBD-forward traits are carried over, though absolute yields and plant size differ. This portfolio approach lets growers choose between biomass efficiency and calendar speed.
Appearance and Morphology
MediKit typically presents as a medium-height hybrid with strong lateral branching and an even canopy when topped early. Internode spacing is moderate, keeping colas tight without overly dense stacking that invites mold in humid rooms. Leaves begin with broader leaflets in early veg and often narrow slightly as the plant matures, reflecting its blended indica and sativa heritage. The result is a plant that is both manageable in tents and capable of filling a screen in scrog setups.
In bloom, MediKit develops conical colas with high calyx density and a moderate leaf-to-calyx ratio that makes trimming straightforward. Buds tend to be lime to forest green with orange to deep tangerine pistils that darken toward maturity. Trichome coverage is generous for a CBD cultivar, often forming a frosty sheen that reads as premium to the eye. The resin heads are typically abundant enough to support dry sift and ice water hash, even though the target cannabinoid is CBD.
Under good lighting, flowers harden well but are less rock-like than some high-THC cookie or kush lines, which improves airflow within the buds. This slightly looser structure, combined with balanced branching, helps reduce botrytis pressure in late flower. Growers often note that MediKit holds its shape without extensive staking, though central colas may still benefit from light support in week 6 and beyond. The plant’s geometry makes it an excellent candidate for even light distribution in small rooms.
Phenotypic variability is modest for a modern seed line, with most plants landing within a predictable height and vigor range. Some phenotypes lean a touch taller with longer internodes, while others compact early and stack more densely. Across phenos, calyx formation and trichome output remain reliably high for a CBD-dominant line. This uniformity translates to consistent bag appeal and ease of harvest planning.
Overall, MediKit’s morphology balances grower-friendly structure with attractive, resinous flowers. The cultivar is visually appealing on the branch and in the jar, which helps retailers position CBD flower as a top-shelf product rather than a compromise. For home growers, the plant’s shape simplifies training and maximizes usable canopy. For commercial rooms, uniformity aids in scheduling and labor efficiency.
Aroma
MediKit is renowned for a bright and layered citrus-forward nose that often leads with lemon and lime zest. Beneath that high note, many cuts show soft mango, papaya, and sweet stone fruit nuances that round the bouquet. Peppery and herbal accents flicker at the edges, offering depth without overshadowing the core citrus theme. The overall impression is clean, uplifting, and surprisingly connoisseur for a CBD-dominant flower.
The aromatic intensity is medium-high when grown correctly, with terpene preservation hinging on late-flower environment and post-harvest handling. When dried at lower temperatures and cured slowly, MediKit expresses a pronounced limonene sparkle that persists for weeks in sealed jars. Growers who rush dry rooms above 20 Celsius often report flatter, soapier citrus and diminished fruit complexity. This cultivar rewards careful curing with a more three-dimensional nose.
On the grind, volatile terpenes open to reveal more herbal detail, often with hints of sweet basil or lemongrass. A subtle woody undertone, consistent with caryophyllene and humulene families, adds a grounding counterpoint. The result is a terpene profile that invites repeat smelling, not just a single-note citrus blast. For consumers used to THC-heavy dessert strains, MediKit’s perfume feels familiar yet crisper and less cloying.
In environments with excellent terpene retention, jar aroma can stay strong for 60 to 90 days without significant fade. Terpene loss accelerates with repeated jar opening, warm storage, and low humidity below 55 percent. Vacuum sealing at stable temperatures prolongs aromatic fidelity, particularly for limonene, which volatilizes quickly. Retailers who manage inventory in cooler back rooms consistently report better shelf aroma for MediKit.
Flavor
The palate mirrors the jar aroma, delivering a clean citrus entry that leans lemon-lime with a sweet finish. Many phenotypes introduce a soft mango or guava thread mid-palate, likely linked to myrcene and ocimene contributions. A faint pepper snap appears on the exhale, typical of beta-caryophyllene, giving the flavor structure and a lingering warmth. The overall taste is fresh and bright rather than heavy or dessert-like.
Vaporization at lower temperatures, around 170 to 185 Celsius, tends to highlight the citrus top notes and tropical mid-range. At higher vape temps or in combustion, the peppery and woody tones become more apparent, and sweetness retreats. This shift can be useful for users who prefer a spicier profile later in sessions. The cultivar’s flavor remains composed and non-harsh when properly flushed and cured.
Water-cured samples lose some of the delicate fruit esters but retain a clean lemon-peel character and a gentle spice. Rosin pressed at lower temperatures preserves a surprising amount of zest, producing an aromatic CBD concentrate suitable for daytime use. In edibles, MediKit infusions carry a light citrus-herbal note that pairs well with lemon lozenges, honey, and tea. The subtlety of the flavor makes it friendly to first-time CBD users.
Because CBD dominant flowers tend to oxidize more slowly than high-THC counterparts in the jar, MediKit’s flavor remains stable with good storage practices. Keeping humidity at 58 to 62 percent and temperatures near 15 to 18 Celsius preserves volatile fractions. Many consumers report enjoyable flavor through the last bowl in a jar, an advantage over strains that fade after two weeks. This stability boosts customer satisfaction in slower-turnover markets.
Cannabinoid Profile
MediKit is engineered for high CBD content with minimal THC, commonly producing a CBD to THC ratio above 20 to 1. Reported flower tests from licensed labs and retailers typically fall in the CBD range of about 15 to 20 percent by dry weight. THC tends to register below 1 percent, often in the 0.2 to 0.8 percent window, keeping intoxication negligible for most users. In absolute terms, a 0.5 gram session of 18 percent CBD flower contains roughly 90 milligrams of CBD in the plant material.
Inhaled bioavailability for cannabinoids varies, with published estimates generally ranging between 20 and 35 percent depending on device and inhalation style. Using a midrange assumption of 30 percent absorption, that 90 milligrams potential would translate to approximately 27 milligrams systemic CBD for a 0.5 gram session. By contrast, oral CBD bioavailability is lower and slower, commonly estimated at 6 to 19 percent. This makes vaporization or smoking an efficient route for near-term effects with MediKit.
Batch-to-batch and pheno-to-pheno variability exists, as with any seed line, but MediKit is regarded as tightly clustered around its CBD target. Environmental stressors, nutrient regimen, and harvest timing can shift ratios modestly, though spikes in THC above 1 percent are uncommon under standard practices. Indoor environments with consistent photoperiods and moderate temperatures tend to reinforce the intended chemotype. Outdoor crops in hotter climates may show slight THC variance but still remain CBD dominant.
Growers focused on compliance often harvest MediKit by trichome maturity cues rather than waiting for heavy ambering. CBD in many cultivars peaks slightly earlier than THC, so taking plants when trichomes are mostly cloudy can support a higher CBD to THC ratio. In rooms with parallel test data, this approach has produced more consistent CBD outcomes. Where available, quick test kits or small batch lab checks refine harvest windows for ratio optimization.
Concentrates derived from MediKit flower can concentrate CBD to two to four times the starting material percentage, depending on method. Rosin and solventless methods typically retain the cultivar’s citrus-forward terpenes, while hydrocarbon extraction can further concentrate cannabinoids if permitted. Consumers should note that even concentrated CBD products from MediKit will still contain trace THC unless specifically remediated. In legal markets, labels will specify exact percentages and pass-fail thresholds relevant to the jurisdiction.
Terpene Profile
MediKit’s terpene ensemble is led by limonene, myrcene, and beta-caryophyllene, with notable support from alpha-pinene and humulene. In mature, well-cured flowers, total terpene content commonly lands near 10 to 20 milligrams per gram of dry flower, depending on cultivation and handling. Within that, limonene often ranges around 2 to 4 mg per gram, imparting the bright citrus top note. Myrcene may present around 2 to 5 mg per gram, contributing tropical fruit and a gentle musk.
Beta-caryophyllene frequently sits between about 1.5 and 3 mg per gram, giving a peppery structure that anchors the bouquet. Alpha-pinene is typically detected near 1 to 2 mg per gram, lending a clean pine and herb nuance that reads as clarity on the palate. Humulene, often 0.5 to 1.5 mg per gram, supports woody and slightly bitter accents that balance sweetness. Some phenotypes add trace linalool or ocimene, adding lavender or green-fruit streaks.
These terpene ranges align with the cultivar’s sensory narratives reported by growers and retailers. Limonene’s volatility means post-harvest decisions strongly impact the nose, with cooler, slower drying preserving brightness. Pinene and caryophyllene are more resilient, often surviving less-than-ideal handling better than limonene. Targeting a gentle drying curve reduces terpene loss by measurable margins in side-by-side room tests.
From a functional standpoint, beta-caryophyllene is notable for its selective activity at the CB2 receptor, which has been studied for inflammation modulation. While whole-plant effects cannot be reduced to single molecules, the balance of limonene, myrcene, and caryophyllene aligns with reported calming yet alert experiences. This composition avoids the heavy sedation sometimes linked to very high myrcene content in other strains. The result is a terpene profile that feels daytime friendly.
For processors, MediKit’s terpene resilience supports solventless extraction that retains a significant fraction of the flavor. Low-temperature rosin techniques consistently carry citrus and spice across, even at modest yields. Hydrocarbon extracts, where legal, can be formulated to reintroduce native terpenes for a fuller spectrum. Across formats, the cultivar’s terpenes contribute to a distinct identity in the CBD category.
Experiential Effects
Because MediKit’s THC content is usually below 1 percent, most users report negligible intoxication even with generous inhalation. The dominant experience is a gentle, clear-headed calm paired with light body relaxation. Onset for inhalation is rapid, commonly within 1 to 5 minutes, with perceived peak around 15 to 45 minutes. Effects typically last 2 to 4 hours depending on dose and individual metabolism.
Many consumers describe improved focus and reduced somatic tension, making MediKit suitable for daytime tasks. The cultivar’s citrus-forward terpene profile reinforces a sense of brightness without jitteriness. Users sensitive to THC-related anxiety often find MediKit noticeably smoother compared to balanced or high-THC hybrids. For some, it functions like a mild herbal tonic rather than an overt psychoactive.
At higher doses, especially with vaporization of large amounts, mild sedation can appear as CBD accumulates. Dry mouth and dry eyes are the most common side effects, similar to other cannabis varieties, though the rates are generally lower with low THC. Rarely, users report lightheadedness if standing quickly after large inhaled doses. As with any cannabinoid product, starting low and pacing intake helps define a comfortable personal range.
Oral consumption through edibles or tinctures derived from MediKit brings a slower, longer arc of effects. Onset often takes 45 to 90 minutes, with duration stretching to 4 to 6 hours or more. Because oral CBD bioavailability is lower, users may perceive a softer effect per milligram compared to inhalation. Splitting doses and pairing with dietary fats can improve consistency.
When blended with trace THC from other sources, some users report additional body ease via the entourage effect. Even MediKit’s inherent trace THC may subtly modulate the overall effect curve. However, individuals with zero-THC requirements should confirm remediation or isolate-based formulations. For flower users, reading a batch’s certificate of analysis clarifies expectations.
Potential Medical Uses
MediKit’s high CBD to low THC ratio makes it a candidate for users seeking functional relief with minimal intoxication. CBD has been studied for seizure disorders, with prescription formulations demonstrating clinically significant reductions in seizure frequency for conditions such as Dravet syndrome and Lennox-Gastaut syndrome. While smoked or vaporized flower is not a substitute for standardized medications, MediKit’s chemotype aligns with non-intoxicating support where legal and appropriate. Individuals with epilepsy should work with medical providers rather than self-medicate.
In the anxiety domain, controlled studies have reported reductions in anxiety scores following single oral doses of CBD in the 300 to 600 milligram range for specific contexts, such as public speaking tests. A typical 0.5 gram session of 18 percent CBD flower contains approximately 90 milligrams CBD in the plant material, with an estimated 27 milligrams absorbed via inhalation under midrange assumptions. This suggests that inhaled MediKit offers subtherapeutic-to-moderate systemic CBD exposures relative to oral trial doses, but with faster onset. Many users still report subjective benefits in situational stress and tension relief at these inhaled ranges.
CBD’s interaction with inflammation pathways has been widely explored in preclinical research, including models involving CB2 receptor activity and cytokine modulation. Beta-caryophyllene, prominent in MediKit’s terpene profile, is also known to engage CB2 selectively, potentially complementing CBD’s effects. Anecdotal reports from MediKit users often highlight gentle relief from exercise-induced soreness and everyday aches. These observations are supportive but not a replacement for clinical evidence.
Sleep outcomes depend on dose and timing. At lower inhaled doses, MediKit’s limonene-forward bouquet and low THC often feel clear and daytime compatible. At higher evening doses, some users experience easier sleep onset due to cumulative body relaxation. Because responses vary, keeping a simple log of timing, dose, and sleep quality can help tailor use.
For individuals looking to reduce THC intake while maintaining a cannabis ritual, MediKit can serve as a bridging or substitution option. Blending MediKit with a THC-dominant strain in a 1 to 1 or 2 to 1 CBD to THC flower mix can soften the psychoactive punch while preserving flavor and aroma. Users often report fewer THC-related side effects such as racing thoughts when CBD is present in meaningful amounts. This strategy is especially common among daytime consumers.
Users subject to workplace testing or strict zero-THC policies should proceed with caution. Even sub-1 percent THC flower can produce detectable metabolites, and individual metabolism varies considerably. When zero-THC is essential, look for products derived from MediKit that have undergone THC remediation or consider CBD isolate alternatives. Always consult local regulations and a qualified clinician for medical decision-making.
Comprehensive Cultivation Guide
Cultivation goals for MediKit center on preserving its terpene brightness and safeguarding its CBD-dominant chemotype while delivering commercial yields. Indoors, the cultivar thrives in a day temperature range of 24 to 28 Celsius and a night range of 18 to 22 Celsius. Relative humidity targets span 65 to 70 percent for seedlings, 55 to 60 percent for veg, and 40 to 50 percent in flower. Keeping vapor pressure deficit within recommended bands reduces disease pressure and stabilizes transpiration.
Lighting targets align with modern LED rooms. In veg, aim for a PPFD of 400 to 600 micromoles per square meter per second, hitting a daily light integral near 20 to 30 mol per square meter. In flower, step up to 700 to 1000 PPFD with a DLI of 35 to 45 mol per square meter for photoperiod plants. CO2 supplementation at 800 to 1200 ppm supports higher PPFD, but is optional if temperatures are kept modest.
The photoperiod MediKit typically flowers to completion in about 60 to 70 days from flip, with many growers harvesting around day 63 to 67. Outdoor harvest in temperate climates usually lands late September to early October, depending on latitude and heat accumulation. For growers focused on the highest CBD to THC ratio, consider harvesting when the majority of trichomes are cloudy with only a few amber heads. This timing often coincides with maximum citrus aroma and preserves a brisk flavor.
Nutrient needs are moderate and respond well to balanced NPK programs with steady calcium and magnesium. In coco or hydro, pH at 5.8 to 6.2 and an electrical conductivity of roughly 1.2 to 1.6 in veg, rising to 1.6 to 2.2 in peak flower, are common success ranges. In living soil systems, avoid over-amending nitrogen late in veg to prevent excessive leafiness and stretch. Supplementing with silica strengthens stems and improves drought resilience.
Training techniques that promote an even canopy pay dividends in yield and terpene retention. Top at the fourth or fifth node and begin low-stress training within a week of topping to open the plant. A scrog net set 30 to 45 centimeters above the pots helps maintain an efficient, flat canopy. Light defoliation at pre-flower and again at week three clears inner sites without stressing the plant.
Integrated pest management is essential, particularly for powdery mildew and botrytis in humid regions. Preventive sprays of biologicals such as Bacillus subtilis in veg reduce mildew risk, while sulfur vaporizers should be used cautiously and only in early veg, never late in flower. Beneficial predatory mites like Amblyseius andersoni help keep broad and russet mites in check. Maintaining clean intakes and regular room sanitation lowers pest incidence.
Water management is a key lever for aroma and density. Allowing pots to dry down to a consistent lower moisture threshold between irrigations encourages healthy root expansion. In coco, frequent small irrigations with a target 10 to 20 percent runoff maintain stable root zone EC. In soil, deeper but less frequent watering avoids chronic saturation that dulls terpenes.
To preserve MediKit’s citrus and fruit-forward terpenes, dial back room temperatures in late flower to the 20 to 24 Celsius range during lights on and 17 to 19 Celsius at lights off. This cooler finish helps lock volatile fractions in the resin heads. Avoid high-intensity defoliation after week three, which can spike stress and degrade aromatics. Gentle airflow prevents microclimates without stripping humidity below 40 percent.
Harvest and post-harvest handling dramatically influence the final product. Aim for a slow dry of 10 to 14 days at around 15 to 18 Celsius and 58 to 62 percent relative humidity. Once stems snap rather than bend, trim and cure in airtight containers, burping daily for the first week and then weekly for four to six weeks. Proper curing can sustain jar aroma for 60 to 90 days, which is valuable for retail rotation.
Yield potential is competitive for a CBD cultivar. Indoors, well-run canopies commonly produce 450 to 550 grams per square meter, with dialed-in scrogs occasionally exceeding that range. Outdoors in favorable climates with large containers or in-ground beds, individual plants can reach 700 to 1000 grams or more. The autoflowering version generally returns 350 to 450 grams per square meter indoors under 18 to 20 hours of light.
Cloning MediKit is straightforward, with high strike rates when cuts are taken from healthy, non-flowering mothers. Use a mild auxin gel or solution and keep humidity at 75 to 85 percent for the first week while providing gentle light at 100 to 200 PPFD. Root formation typically occurs in 8 to 12 days, after which humidity can be stepped down gradually. Transplant into final media once roots are established and branching.
For growers in warm regions, selecting slightly airier phenotypes can reduce late-season botrytis risk. Conversely, in cooler climates or under high-CO2 indoor runs, picking denser phenotypes can bump yield without sacrificing aroma. Keeping detailed logs on each phenotype’s stretch, node spacing, and harvest analytics facilitates better selection over successive cycles. If local labs are accessible, test a few phenos to confirm CBD to THC ratios and lean into the winners.
Compliance considerations matter for CBD-dominant crops. In jurisdictions with tight THC caps for hemp-like categories, consider harvesting a few days earlier and favoring phenotypes that consistently test below 1 percent THC. Where adult-use rules apply, MediKit’s typical THC below 1 percent rarely triggers psychoactive labeling but still requires standard potency testing. Clear labeling and batch certificates build consumer trust.
Finally, keep in mind that MediKit’s breeder, Buddha Seeds, is referenced in genealogy listings alongside clone-only notables and unknown-strain branches, which contextualizes its modern hybrid nature. Media indices such as CannaConnection list Medikit Auto among related cultivars, confirming the line’s expansion beyond the photoperiod format. Leaning on this ecosystem of information supports realistic expectations for plant behavior and chemotype. With careful environmental control and gentle handling, MediKit rewards cultivators with bright, aromatic CBD flower that stands up in the top shelf.
